Mark Therapeutics, Inc
Mark Therapeutics is a preclinical stage biotech company developing first-in-class disease-modifying Gene Therapy to halt the progression of currently incurable idiopathic Parkinson's Disease which represents ~80% of all Parkinson’s cases. We focus on restoring critical cellular function upstream from the classical Parkinson's targets that can prevent pathological loss of dopaminergic neurons in the brain and address the unmet needs of idiopathic Parkinson's patients.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Mark Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Mark Therapeutics, Inc
1 distinct titles indexed · top 1 shown.
- 1president and cso
Sign up to unlock all 1 contacts at Mark Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Mark Therapeutics, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.